
Magellan Health, Inc. MGLN
Country |
|
IPO year |
- |
Industry |
Health care |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
25.8 M |
Market Cap[1] |
$ 2.49 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Health care"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
- | -2.32 % | $ 107 B | NYSE,SPB | ||
|
Cigna Corporation
CI
|
$ 271.25 | -2.58 % | $ 71.5 B | NYSE,SPB | ||
|
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | NYSE | ||
|
CVS Health Corporation
CVS
|
$ 79.33 | 0.62 % | $ 101 B | NYSE,SPB | ||
|
Centene Corporation
CNC
|
$ 37.3 | -0.67 % | $ 18.4 B | NYSE,SPB | ||
|
Molina Healthcare
MOH
|
$ 145.88 | 0.57 % | $ 7.7 B | NYSE,SPB | ||
|
NovoCure Limited
NVCR
|
$ 10.58 | -3.82 % | $ 1.18 B | Nasdaq Global Select Market,SPB | ||
|
UnitedHealth Group Inc.
UNH
|
$ 304.33 | -0.84 % | $ 276 B | NYSE,SPB | ||
|
Humana
HUM
|
$ 192.15 | -2.62 % | $ 23.1 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.